Tag: PRESIDE trial

#VisualAbstract: Continued enzalutamide after progression of metastatic prostate cancer improves progression-free survival

byMinjee Kim

October 26, 2022

1. The median progression-free survival was higher in the enzalutamide vs the placebo group (9.5 months vs 8.3 months) 2. ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Thrombolysis-to-puncture time greater than 70 minutes decreases odds of successful thrombectomy
#VisualAbstract: Obicetrapib Reduced LDL Cholesterol in Patients at High Cardiovascular Risk
St. Louis hospital-based violence intervention program did not significantly affect reinjury outcomes

No Result

View All Result